Trial · NCT04375397
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants Alive and Without Respiratory Failure Through Day 28 | Through Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | percentage of participants | NUMBER |
| SECONDARY | Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | At Day 14 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug; participants with baseline and Day 14 score data | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Median Reduction in Days Spent on Supplemental Oxygen | Up to Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | days | MEDIAN |
| SECONDARY | All-Cause Mortality at Study Days 7, 14, 21, and 28 | At Study Days 7, 14, 21, and 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Experiencing Respiratory Failure or Death on Study Days 7, 14, 21, and 28 | At Study Days 7, 14, 21, and 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | percentage of participants | NUMBER |
| SECONDARY | Mechanical Ventilation-Free Survival | Up to Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | days | MEDIAN |
| SECONDARY | Days on Mechanical Ventilation | Up to Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | days | MEDIAN |
| SECONDARY | Median Duration of Hospitalization | Up to Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | days | MEDIAN |
| SECONDARY | Time to Discharge From Hospital | Up to Day 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug | days | MEDIAN |
| SECONDARY | Partial Pressure of Oxygen in Arterial Blood (PaO2) to Fraction of Inspired Oxygen (FiO2) Ratio | At Study Days 7, 14, 21, and 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug. Participants with non-missing baseline and at least one post-baseline value are included in the analyses. | mmHg | MEAN |
| SECONDARY | Oxygenation Index | At Study Days 7, 14, 21, and 28 | Full Analysis Set (FAS): all randomized participants who received at least 1 dose of study drug. Participants with non-missing baseline and at least one post-baseline value are included in the analyses. | units on a scale | MEAN |
| SECONDARY | Number of Participants With Adverse Events | From first dose of study drug until 30 days following last dose of study drug (up to 70 days) | Safety Population: all participants who received at least 1 dose of study drug | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04375397/outcomes